Rick E. Winningham - 18 Feb 2022 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Issuer symbol
TBPH
Transactions as of
18 Feb 2022
Net transactions value
-$218,243
Form type
4
Filing time
23 Feb 2022, 17:38:18 UTC
Previous filing
23 Nov 2021
Next filing
01 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Tax liability $218,243 -22,710 -1.7% $9.61 1,279,300 18 Feb 2022 Direct F1
holding TBPH Ordinary Shares 92,567 18 Feb 2022 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.